In situ antitumor vaccination: Targeting the tumor microenvironment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In situ antitumor vaccination: Targeting the tumor microenvironment
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-02-07
DOI
10.1002/jcp.29551
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- First-in-human study with intratumoral administration of a CD40 agonistic antibody, ADC-1013, in advanced solid malignancies
- (2019) Sandra M. M. Irenaeus et al. INTERNATIONAL JOURNAL OF CANCER
- Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunity
- (2019) Masanori Onda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
- (2019) Alessandra Lopes et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A20 prevents inflammasome-dependent arthritis by inhibiting macrophage necroptosis through its ZnF7 ubiquitin-binding domain
- (2019) Apostolos Polykratis et al. NATURE CELL BIOLOGY
- Development of an adaptive electroporation system for intratumoral plasmid DNA delivery
- (2018) Douglas W. Brown et al. BIOELECTROCHEMISTRY
- Radiation followed by OX40 stimulation drives local and abscopal antitumor effects in an anti-PD1-resistant lung tumor model
- (2018) Sharareh Niknam et al. CLINICAL CANCER RESEARCH
- Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters
- (2018) C. Burkart et al. GENE THERAPY
- Adoptive Transfer of IL13Rα2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma
- (2018) Katarzyna C. Pituch et al. MOLECULAR THERAPY
- The pleiotropic effects of TNFα in breast cancer subtypes is regulated by TNFAIP3/A20
- (2018) Eunmi Lee et al. ONCOGENE
- Combination of radiation and interleukin 12 eradicates large orthotopic hepatocellular carcinoma through immunomodulation of tumor microenvironment
- (2018) Chia-Jen Wu et al. OncoImmunology
- E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs
- (2018) Enguang Bi et al. JOURNAL OF CLINICAL INVESTIGATION
- Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunity
- (2018) David A. Knorr et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Designing and building oncolytic viruses
- (2017) Justin Maroun et al. Future Virology
- Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
- (2017) Karsten Geletneky et al. MOLECULAR THERAPY
- A20 promotes metastasis of aggressive basal-like breast cancers through multi-monoubiquitylation of Snail1
- (2017) Ji-Hyung Lee et al. NATURE CELL BIOLOGY
- MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway
- (2017) Zhen Zheng et al. Cell Death & Disease
- Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer
- (2016) Hong Liu et al. CLINICAL CANCER RESEARCH
- Safety Studies in Tumor and Non-Tumor-Bearing Mice in Support of Clinical Trials Using Oncolytic VSV-IFNβ-NIS
- (2016) Lianwen Zhang et al. Human Gene Therapy Clinical Development
- Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy
- (2016) Hasan Rehman et al. Journal for ImmunoTherapy of Cancer
- Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma
- (2015) A. H. Rook et al. BLOOD
- Intratumoral immunotherapy for melanoma
- (2015) Manisha Singh et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cationic nanocarriers induce cell necrosis through impairment of Na+/K+-ATPase and cause subsequent inflammatory response
- (2015) Xiawei Wei et al. CELL RESEARCH
- Intratumoral Injection of Ad-ISF35 (Chimeric CD154) Breaks Tolerance and Induces Lymphoma Tumor Regression
- (2015) Mauricio Urquiza et al. HUMAN GENE THERAPY
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 1 Trial of Bi-shRNA STMN1 BIV in Refractory Cancer
- (2015) Minal Barve et al. MOLECULAR THERAPY
- In Vivo Silencing of A20 via TLR9-Mediated Targeted SiRNA Delivery Potentiates Antitumor Immune Response
- (2015) Floriane C. M. Braun et al. PLoS One
- Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells
- (2015) M. J. Schuijs et al. SCIENCE
- Antitumor and Adjuvant Activity of λ-carrageenan by Stimulating Immune Response in Cancer Immunotherapy
- (2015) Min Luo et al. Scientific Reports
- Inhibition of A20 expression in tumor microenvironment exerts anti-tumor effect through inducing myeloid-derived suppressor cells apoptosis
- (2015) Bin Shao et al. Scientific Reports
- In-situ tumor vaccination: Bringing the fight to the tumor
- (2015) Robert H Pierce et al. Human Vaccines & Immunotherapeutics
- Biodegradable Polymeric Nanoparticles Show High Efficacy and Specificity at DNA Delivery to Human Glioblastoma in Vitro and in Vivo
- (2014) Hugo Guerrero-Cázares et al. ACS Nano
- VISTA Is an Immune Checkpoint Molecule for Human T Cells
- (2014) J. L. Lines et al. CANCER RESEARCH
- Armed Oncolytic Virus Enhances Immune Functions of Chimeric Antigen Receptor-Modified T Cells in Solid Tumors
- (2014) N. Nishio et al. CANCER RESEARCH
- Intratumoral Immunization: A New Paradigm for Cancer Therapy
- (2014) A. Marabelle et al. CLINICAL CANCER RESEARCH
- Effective Innate and Adaptive Antimelanoma Immunity through Localized TLR7/8 Activation
- (2014) Manisha Singh et al. JOURNAL OF IMMUNOLOGY
- Attenuated A20 expression of acute myeloid leukemia-derived dendritic cells increased the anti-leukemia immune response of autologous cytolytic T cells
- (2014) Xiaoying Zhang et al. LEUKEMIA RESEARCH
- Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis
- (2014) Lieselotte Vande Walle et al. NATURE
- Tackling the cancer stem cells — what challenges do they pose?
- (2014) Diwakar R. Pattabiraman et al. NATURE REVIEWS DRUG DISCOVERY
- The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells
- (2014) M. Giordano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
- (2014) M. L. Davila et al. Science Translational Medicine
- Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity
- (2014) P. S. Adusumilli et al. Science Translational Medicine
- A20-Deficient Mast Cells Exacerbate Inflammatory Responses In Vivo
- (2014) Klaus Heger et al. PLOS BIOLOGY
- Molecular Pathways: Coexpression of Immune Checkpoint Molecules: Signaling Pathways and Implications for Cancer Immunotherapy
- (2013) C. J. Nirschl et al. CLINICAL CANCER RESEARCH
- Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8+ T-Cell-Dependent Tumor Eradication and Decreases Risk of Toxic Side Effects
- (2013) M. F. Fransen et al. CLINICAL CANCER RESEARCH
- Turning Tumors into Vaccines: Co-opting the Innate Immune System
- (2013) Jasper G. van den Boorn et al. IMMUNITY
- Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
- (2013) Aurélien Marabelle et al. JOURNAL OF CLINICAL INVESTIGATION
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
- (2013) Tyler R. Simpson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Stathmin overexpression identifies high risk for lymphatic metastatic recurrence inpN0esophageal squamous cell carcinoma patients
- (2013) Javed Akhtar et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial
- (2013) Aimée HMM Arits et al. LANCET ONCOLOGY
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- The Deubiquitinase A20 Mediates Feedback Inhibition of Interleukin-17 Receptor Signaling
- (2013) A. V. Garg et al. Science Signaling
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
- (2013) R. J. Brentjens et al. Science Translational Medicine
- Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines
- (2013) Barbara A. Fox et al. TRENDS IN PARASITOLOGY
- Intratumoral injection of attenuated Salmonella vaccine can induce tumor microenvironmental shift from immune suppressive to immunogenic
- (2013) Eun-Hye Hong et al. VACCINE
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Targeting the Tumor Microenvironment for Cancer Therapy
- (2012) N. E. Sounni et al. CLINICAL CHEMISTRY
- The extracellular matrix: A dynamic niche in cancer progression
- (2012) Pengfei Lu et al. JOURNAL OF CELL BIOLOGY
- Immune-Mediated Regression of Established B16F10 Melanoma by Intratumoral Injection of Attenuated Toxoplasma gondii Protects against Rechallenge
- (2012) J. R. Baird et al. JOURNAL OF IMMUNOLOGY
- Toll-Like Receptor 3 Expressing Tumor Parenchyma and Infiltrating Natural Killer Cells in Hepatocellular Carcinoma Patients
- (2012) Valerie Chew et al. JNCI-Journal of the National Cancer Institute
- In Situ Vaccination with CD204 Gene-Silenced Dendritic Cell, not Unmodified Dendritic Cell, Enhances Radiation Therapy of Prostate Cancer
- (2012) C. Guo et al. MOLECULAR CANCER THERAPEUTICS
- The Efficacy Versus Toxicity Profile of Combination Virotherapy and TLR Immunotherapy Highlights the Danger of Administering TLR Agonists to Oncolytic Virus-treated Mice
- (2012) Diana M Rommelfanger et al. MOLECULAR THERAPY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting pattern recognition receptors in cancer immunotherapy
- (2012) Nadège Goutagny et al. Targeted Oncology
- In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study
- (2011) Y. H. Kim et al. BLOOD
- Heavy Chain Ferritin siRNA Delivered by Cationic Liposomes Increases Sensitivity of Cancer Cells to Chemotherapeutic Agents
- (2011) X. Liu et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial Cancer
- (2011) J. Trovik et al. CLINICAL CANCER RESEARCH
- The Ubiquitin-Editing Protein A20 Prevents Dendritic Cell Activation, Recognition of Apoptotic Cells, and Systemic Autoimmunity
- (2011) Mirjam Kool et al. IMMUNITY
- VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
- (2011) Li Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
- (2011) Caroline J. Breitbach et al. NATURE
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- IFN Markedly Cooperates with Intratumoral Dendritic Cell Vaccine in Dog Tumor Models
- (2010) K. Mito et al. CANCER RESEARCH
- In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
- (2010) Joshua D. Brody et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting A20 Decreases Glioma Stem Cell Survival and Tumor Growth
- (2010) Anita B. Hjelmeland et al. PLOS BIOLOGY
- Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin
- (2009) A. M. LeBeau et al. MOLECULAR CANCER THERAPEUTICS
- T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy
- (2008) R. Houot et al. BLOOD
- The Ubiquitin-Editing Enzyme A20 Restricts Nucleotide-Binding Oligomerization Domain Containing 2-Triggered Signals
- (2008) Osamu Hitotsumatsu et al. IMMUNITY
- Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma
- (2008) Adil I. Daud et al. JOURNAL OF CLINICAL ONCOLOGY
- A20 is an antigen presentation attenuator and its inhibition overcomes regulatory T cell–mediated suppression
- (2008) Xiao-Tong Song et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More